OmniVision Technologies, Inc. (NASDAQ:OVTI) Accelerated R&D And Expansion Initiatives

944

Dallas, Texas 12/05/2014 (FINANCIALSTRENDS) – OmniVision Technologies, Inc. (NASDAQ:OVTI) recently reported 2Q15 and 1H15 financial results for period ended October 31, 2014. The company reported 6.61% and strong 48.6% YoY increase in its 2Q15 and 1H15 earnings to $28.04 million and $73.37 million, respectively. It translates to earnings of $0.47 per diluted share in 2Q15 and $1.25 per diluted share in 1H15.

The earnings growth is particularly significant given the decline in 2Q15 revenues and higher R&D investment. OmniVision reported 2Q15 revenues of $394.04 million as compared to $397.24 million in 2Q14 and $406.5 million in 1Q15. R&D expenses increased to $34.18 million in 2Q15 from $29.12 million in 2Q14 and $68.91 million in 1H15 from $56.82 million in 1H14.

Operational Highlights and Outlook

Shaw Hong, CEO of OmniVision Technologies, Inc. (NASDAQ:OVTI), expressed that the company’s mobile phone and automotive products led the strong growth through 2Q15. The company also launched high-performance PureCel-S products, which underscores its technology leadership. Mr. Hong also showed confidence in the company’s execution in China and opportunities in India, which is emerging as a key geography for OmniVision.

OmniVision expects 3Q15 revenues to remain in the range of $275 to $305 million and earnings of $0.09 to $0.25 per diluted share. However, the company expects its non-GAAP earnings to be between $0.22 and $0.38 per diluted share, excluding the estimated expense and related tax effects.

Other Financial Indicators

OmniVision Technologies, Inc. (NASDAQ:OVTI) reported non-GAAP net income of $36.9 million or $0.60 per diluted share in 2Q15. Gross margin improved significantly to 22% during 2Q15 from 18.8% in 2Q14. The company ended the period with cash and cash equivalents of $313.99 million as compared to $297.95 million as at April 30, 2014.

OmniVision outperformed the street expectations by significant margin. Analysts surveyed by Zacks Investment Research predicted revenues of $375.8 million and adjusted earnings of $0.5 per share on average.

Subscribe to get your free report!

* indicates required
*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.